VBI gets $50 million debt financing facility via K2 HealthVentures

By Devika Patel

Knoxville, Tenn., May 27 – VBI Vaccines Inc. secured up to $50 million through a debt financing facility with K2 HealthVentures, according to a press release.

Upon closing, VBI received the first tranche of $20 million and fully repaid the company’s $15 million loan facility with Perceptive Advisors.

A second tranche of up to $20 million will become available to the company upon achieving certain milestones and a final tranche of up to $10 million will be available at the discretion of K2 HealthVentures.

The biopharmaceutical company is based in Cambridge, Mass.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.